Effect of Maharishi Amrit Kalash (MAK-5) on Brain Opioid Receptors and Neuropeptides
Publication
The Journal of Research and Education in Indian Medicine, Vol. 10, No. 1, pp. 1-8, 1991.
Authors
Hari M. Sharma,* Silva Hanissian,** Anil K. Rattan,** Stephen L. Stern,† and Gopi A. Tejwani.**
Conducted at
*Department of Pathology,
**Department of Pharmacology, and
†Division of Psychiatry, College of Medicine, The Ohio State University, Columbus, OH 43210
Summary
MAK-5 was tested for its effects on opioid receptors in the brain, and on neuropeptides.
In vitro tests using animal brain tissue showed that MAK-5 inhibited the binding of mu, kappa, and delta opioid receptors. Opioid peptides binding to these receptors are known to trigger changes in analgesia, behavior, appetite, endocrine and autonomic functions, and modulation of the immune system.
Levels of Substance P, a neurotransmitter involved in pain pathways and pulmonary and gastrointestinal inflammation, showed a significant decrease in human subjects using MAK-5 for three months. Levels decreased from 255.8 pg/ml to 36.0 pg/ml over the 3-month period (p<0.01).
This suggests MAK-5 may be helpful in relieving pain, as well as pulmonary and gastrointestinal inflammation.
Please Note
MAK-5 is now called Amrit Kalash Ambrosia.
© 1999, 2021 Maharishi AyurVeda Products International, Inc. (MAPI). All Rights Reserved. MAPI does not provide medical advice, diagnosis or treatment. These statements have not been evaluated by the Food and Drug Administration. Products are not intended to diagnose, treat, cure or prevent any disease. See additional information.
